A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma

NCT00628758 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Symbicort TBH - Turbuhaler
DRUG: beta-II-agonist, inhale steroid

Sponsor

AstraZeneca